Verition Fund Management LLC lifted its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 9.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 122,016 shares of the company’s stock after purchasing an additional 10,322 shares during the period. Verition Fund Management LLC’s holdings in Option Care Health were worth $2,165,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Neo Ivy Capital Management acquired a new stake in shares of Option Care Health during the fourth quarter worth about $91,000. Strs Ohio increased its position in shares of Option Care Health by 64.9% during the first quarter. Strs Ohio now owns 9,400 shares of the company’s stock worth $166,000 after purchasing an additional 3,700 shares in the last quarter. Qtron Investments LLC acquired a new stake in shares of Option Care Health during the first quarter worth about $190,000. Clearbridge Investments LLC acquired a new position in Option Care Health in the 1st quarter valued at about $202,000. Finally, Amalgamated Bank acquired a new position in Option Care Health in the 1st quarter valued at about $203,000. Institutional investors and hedge funds own 47.64% of the company’s stock.
Several brokerages recently issued reports on OPCH. Zacks Investment Research cut Option Care Health from a “hold” rating to a “sell” rating in a research report on Wednesday, July 14th. The Goldman Sachs Group upgraded Option Care Health from a “neutral” rating to a “buy” rating and boosted their price target for the company from $20.00 to $25.00 in a research report on Monday. One analyst has rated the stock with a sell rating and five have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $22.36.
Option Care Health (NASDAQ:OPCH) last released its earnings results on Thursday, May 6th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.02 by ($0.04). Option Care Health had a return on equity of 0.92% and a net margin of 0.29%. The business had revenue of $759.20 million for the quarter, compared to analyst estimates of $752.47 million. During the same quarter in the previous year, the firm posted ($0.11) EPS. The business’s revenue for the quarter was up 7.6% on a year-over-year basis. As a group, research analysts predict that Option Care Health, Inc. will post 0.36 earnings per share for the current year.
In other news, Director Harry M. Jansen Kraemer, Jr. purchased 40,000 shares of the firm’s stock in a transaction dated Wednesday, May 19th. The shares were acquired at an average price of $17.59 per share, with a total value of $703,600.00. Following the purchase, the director now directly owns 83,760 shares of the company’s stock, valued at $1,473,338.40. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Michael H. Shapiro purchased 2,500 shares of the firm’s stock in a transaction dated Tuesday, May 11th. The shares were purchased at an average cost of $16.33 per share, for a total transaction of $40,825.00. Following the purchase, the chief financial officer now directly owns 2,500 shares in the company, valued at $40,825. The disclosure for this purchase can be found here. Insiders have acquired a total of 53,355 shares of company stock worth $922,938 in the last quarter. 47.00% of the stock is currently owned by insiders.
Option Care Health Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies.
Featured Article: What is FinTech?
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH).
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.